# Bioventus Inc.: Form 8-K, filed Jan 3, 2025

- Company: [Bioventus Inc.](/companies/bvs.md) (CIK 1665988)
- Form: 8-K
- Filed: 2025-01-03
- Accepted by EDGAR: Jan 3, 2025, 16:09 ET
- Period: 2024-12-31
- Accession: 0001628280-25-000253
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1665988/000162828025000253/bvs-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1665988/000162828025000253/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1665988/000162828025000253/bvs-20241231.htm

Filed Jan 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-000253. Last ingested by Listed: Nov 2, 2026, 17:44 ET. No prices; not investment advice.